More

    DeepHelix announces ‘Deepcellpic’, an automatic white blood cell image classification solution, at CES 2024… “We will continue to develop customized image classification algorithms!”

    DeepHelix announces 'Deepcellpic', an automatic white blood cell image classification solution, at CES 2024...  “We will continue to develop customized image classification algorithms!”
    Overview of Deepcellpic’s white blood cell image automatic classification algorithm | Provided by – Deephelix

    DeepHelix (CEO Kim Jong-rak) announced that it will participate in CES 2024, the world’s largest IT and home appliance exhibition, to be held in Las Vegas, USA in January next year.

    DeepHelix is ​​a company that has been conducting business by attracting various projects and contests related to artificial intelligence (AI) technology.

    Furthermore, while seeking to expand its business into the medical field, DeepHelix has secured its own technological capabilities by developing its own algorithm to classify white blood cell images taken through a microscope. The company explains that in order to reduce errors due to diversity in an actual clinical environment, variables are minimized by using object detection and color normalization techniques, thereby achieving high classification accuracy.

    Through this, DeepHelix developed ‘Deepcellpic’, an automatic white blood cell image classification solution that is smaller and lighter than existing professional medical equipment, and plans to showcase the prototype at the upcoming CES 2024 to identify demand from potential global customers.

    Unlike existing equipment that requires manual photography, Deepcellpic provides differentiated convenience in automatically acquiring multiple images with a single request through software. DeepHelix’s self-developed algorithm prevents duplication among massive images and maintains classification accuracy of 97% through various deep learning techniques.

    Deepcellpic focuses on identifying clinical significance by classifying leukocyte diversity, and can be used to replace and automate the manual work of pathologists and improve the efficiency of disease diagnosis and patient treatment monitoring. At the same time, the user-friendly design and fast test time are also considered as Deepcellpic’s strengths, and it boasts versatility in various blood testing situations due to its excellent compatibility with various staining reagents.

    A DeepHelix official said, “The currently produced Deepcellpic is a prototype, and prior to full-scale commercialization, tasks remain such as verifying effectiveness in a clinical environment and establishing infrastructure for stable production.” He added, “To this end, we have signed an MOU with Kosin University Gospel Hospital.” During the product development process, clinical white blood cell images were provided by Seoul National University Bundang Hospital and research was conducted. “In this way, we will conduct verification based on the network capabilities of large domestic hospitals,” he said.

    “Furthermore, another goal is to secure global capabilities by exporting Deepcellpic beyond Korea to major medically advanced countries such as North America. In addition, we are conducting research and development to analyze various medical image data such as thyroid, tonsil, and chest images. “He said of his future plans, “We plan to continue the growth of the company by continuing to closely collaborate with hospitals and medical institutions at home and abroad to develop artificial intelligence algorithms required in various fields and commercialize them.”

    Meanwhile, ‘CES’, the world’s largest IT exhibition hosted by the Consumer Technology Association (CTA), is an exhibition where you can see the flow of innovative technologies around the world at a glance and is held every January in Las Vegas, USA. AVING News, which has covered CES for 18 consecutive years, has reported CES news around the world every year since 2006, and has been selected through ‘BEST OF CES’ and ‘BEST OF MADE IN KOREA’, which select the best innovative products, companies and technologies. has been in progress. In addition, CES on-site issues are vividly conveyed through ‘AVING LIVE’.

    The CES 2024 Seoul Unified Hall will be operated at the largest scale in terms of exhibition area, number of participating companies, and number of participating supporters since Seoul City’s first participation in CES in 2020. The Seoul Integration Center, in which 13 organizations collaborate and participate, is an important step in Seoul’s efforts to make Seoul a mecca for startups, and 17 of the companies participating in the Seoul Integration Center proved this by receiving innovation awards. The participating institutions in the Seoul Unification Center are ▲SBA ▲Seoul Bio Hub ▲Campus Town ▲AI Yangjae Hub ▲Gwanak-gu ▲Yonsei University ▲Korea University ▲Chung-Ang University ▲Sogang University ▲Kookmin University ▲Hanyang University ▲Konkuk University ▲Kyunghee University. Not only the Seoul Metropolitan Government, institutions, and companies, but also supporters through industry-academia cooperation are matched 1:1 with companies, and 85 supporters, the largest number, will participate.

    * Special reporters: Joseph Choe, Kidai Kim, Dongkwan Kim, Mokkyung Lee, Sangun Choi, Seung Hyun Nam, Sunghwan Kim, Taeuck Lim, Min Choi

    → Go to the CES 2024 news special page